![Nate Hukill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Nate Hukill is the founder of Social SafeGuard, Inc. (founded in 2014).
He is currently a Managing Partner at CR Group LP since 2009.
Mr. Hukill has held former positions as a Director at Complete Genomics, Inc. (2007-2009), Epocal, Inc. (2007-2008), Valeritas Holdings, Inc. (2016), and Valeritas, Inc. He also served as a Non-Independent Non-Executive Director at AFT Pharmaceuticals Ltd. (2014-2020) and as a Portfolio Manager at Highland Capital Management LP (2005-2009).
Mr. Hukill has an educational background with an MBA from the University of Virginia Darden School of Business (conferred in 2005) and an undergraduate degree from the University of Colorado Boulder.
Aktive Positionen von Nate Hukill
| Unternehmen | Position | Beginn |
|---|---|---|
CR Group LP
 CR Group LP Investment ManagersFinance CRG invests in both public and private small & middle market companies located across the globe, primarily in the United States, Europe, Australia and Canada with revenues under USD 300 million. The firm targets companies operating in the fields of consumer health, life sciences, and healthcare services & IT. sectors. It provides financing in the form of debt and equity for growth transactions with an investment size ranging from USD 20 to 300 million. | Präsident | 01.01.2009 |
Ehemalige bekannte Positionen von Nate Hukill
| Unternehmen | Position | Ende |
|---|---|---|
| AFT PHARMACEUTICALS LIMITED | Direktor/Vorstandsmitglied | 22.06.2020 |
| VALERITAS HOLDINGS, INC. | Direktor/Vorstandsmitglied | 01.12.2016 |
Highland Capital Management LP
 Highland Capital Management LP Investment ManagersFinance Highland is a global alternative fixed income manager that specializes in bank loans, high yield credit, distressed debt, structured products, real assets, and long-short equities, with a global geographic reach. The firm’s investment philosophy is rooted in a value-oriented, long-term approach, which combines bottom-up research with top-down technical market analysis. Their analysts follow a rigorous and time-tested bottom-up credit analysis for each credit they manage. Highland is an activist firm and is included in the SharkWatch50 as one of the 50 most prominent and impactful activist investors. | Portfolio Manager-Fixed Income | 01.01.2009 |
| COMPLETE GENOMICS, INC. | Direktor/Vorstandsmitglied | 01.01.2009 |
Epocal, Inc.
 Epocal, Inc. Medical SpecialtiesHealth Technology Develops and manufactures biochips and micro-fabrication for drug development applications | Corporate Officer/Principal | 31.12.2008 |
Ausbildung von Nate Hukill
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
69
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Highland Capital Management LP
Highland Capital Management LP Investment ManagersFinance Highland is a global alternative fixed income manager that specializes in bank loans, high yield credit, distressed debt, structured products, real assets, and long-short equities, with a global geographic reach. The firm’s investment philosophy is rooted in a value-oriented, long-term approach, which combines bottom-up research with top-down technical market analysis. Their analysts follow a rigorous and time-tested bottom-up credit analysis for each credit they manage. Highland is an activist firm and is included in the SharkWatch50 as one of the 50 most prominent and impactful activist investors. | Finance |
Complete Genomics, Inc.
 Complete Genomics, Inc. BiotechnologyHealth Technology Develops and markets DNA sequencing technology | Health Technology |
Epocal, Inc.
Epocal, Inc. Medical SpecialtiesHealth Technology Develops and manufactures biochips and micro-fabrication for drug development applications | Health Technology |
Valeritas Holdings, Inc.
 Valeritas Holdings, Inc. Medical SpecialtiesHealth Technology Develops and commercializes insulin drug delivery devices | Health Technology |
Smith Barney Asset Management
 Smith Barney Asset Management Investment ManagersFinance Provides investment services | Finance |
Valeritas, Inc.
 Valeritas, Inc. Medical SpecialtiesHealth Technology Develops and commercializes drug delivery solutions for the treatment of diabetes | Health Technology |
AFT Pharmaceuticals Ltd.
 AFT Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
CR Group LP
CR Group LP Investment ManagersFinance CRG invests in both public and private small & middle market companies located across the globe, primarily in the United States, Europe, Australia and Canada with revenues under USD 300 million. The firm targets companies operating in the fields of consumer health, life sciences, and healthcare services & IT. sectors. It provides financing in the form of debt and equity for growth transactions with an investment size ranging from USD 20 to 300 million. | Finance |
University of Virginia Darden School of Business
 University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Colorado Boulder
 University of Colorado Boulder Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Social SafeGuard, Inc.
 Social SafeGuard, Inc. Packaged SoftwareTechnology Services Develops digital risk protection platform that securely enables humans to interact on any digital channel | Technology Services |
Wählen Sie MarketScreener 
